Skip to content

Over-the-counter drug favorite Merck sells popular brands to Bayer

By Catholic Online (NEWS CONSORTIUM)
5/6/2014 (2 years ago)
Catholic Online (www.catholic.org)

Merck produces Coppertone, Claritin and Dr. Scholl's Foot Pads

The maker of such over-the-counter favorites as Coppertone, Claritin and Dr. Scholl's has sold its consumer care brands to Germany's Bayer for $14.2 billion. The latest deal between Merck and Bayer is just the latest deal in a wave of mergers and acquisitions sweeping the healthcare industry.

Merck was the biggest U.S. spender on research and development in pharmaceuticals and biotech in 2012. Merck has been undergoing restructuring in order to focus on vaccines and treatments for cancer and diabetes.

Merck was the biggest U.S. spender on research and development in pharmaceuticals and biotech in 2012. Merck has been undergoing restructuring in order to focus on vaccines and treatments for cancer and diabetes.

Highlights

By Catholic Online (NEWS CONSORTIUM)
Catholic Online (www.catholic.org)
5/6/2014 (2 years ago)

Published in Business & Economics

Keywords: Merck, Bayer, buyout, over-the-counter


LOS ANGELES, CA (Catholic Online) - According to Bayer, the deal would add $2.2 billion in annual sales to its non-prescription business. This would make Bayer the second biggest provider of over the counter products worldwide.

Merck was the biggest U.S. spender on research and development in pharmaceuticals and biotech in 2012. Merck has been undergoing restructuring in order to focus on vaccines and treatments for cancer and diabetes.

Find out how you can fill the gaps to end world hunger - by going here!

After-tax proceeds from the sale are likely to be between $8 and $9 billion. The profits will be used to develop its most promising products, such as skin and lung cancer treatment MK-3475, according to Merck.

Both Bayer and Merck have agreed to work together to develop new compounds to treat various cardiovascular diseases. Under the agreement, Merck will pay Bayer $1 billion upfront. Payments of $1.1 billion related to that agreement will unfold later on.

Corporate activity in the sector has been fruitful thus far for 2014. The value of pharmaceutical deals announced this year is running at its highest level since 2009, at a record level across the broader healthcare sector.

Driven by low interest rates that make it cheaper to borrow money and swollen corporate treasure chests has spurred on a buying spree in the pharmaceutical world. Many companies have a lot of cash on hand. There are also ongoing pushes for firms to expand their drug pipelines as patents expire and competition heats up.

The best may be yet to come. By far the biggest potential acquisition currently on the cards is Pfizer's attempt to buy AstraZeneca for $106 billion. AstraZeneca's board has rejected Pfizer's bid, and the U.S. firm now has until May 26 to change its mind. If this fails, Pfizer then has to decide whether to withdraw or go hostile by making an offer direct to shareholders.

---


'Help give every student and teacher Free resources for a world-class moral Catholic education'


Copyright 2017 - Distributed by THE CALIFORNIA NETWORK

Pope Francis Prayer Intentions for APRIL 2017
Young People.
That young people may respond generously to their vocations and seriously consider offering themselves to God in the priesthood or consecrated life.


Comments


More Business & Economics

Why Google, YouTube, Facebook and others need to be broken up -- or regulated Watch

Image of Monopolies are back, and they're taking over everything.

Is to time to break up the monopolies? As Google, Facebook and others grow larger, calls for their breakup are emerging. There is an urgent ... continue reading


Tesla Model 3 may fall short of forecasts, but it will still change the world Watch

Image of The Tesla Model 3 is the Model T Ford of electric cars.

The Tesla Model 3 is a game changer for the auto industry. It is a reasonably priced, well-designed electric car that looks good. It has ... continue reading


Pope Francis' nightmare? World's richest 8 men own as much as 3.6 billion people Watch

Image of The richest one percent own what the world's poorest have COMBINED.

During an interview with Dutch newspaper Straatinieuws, Pope Francis explained: "I would like a world without the poor. We must fight for ... continue reading


Is YOUR job in danger? Thousands of Americans to lose jobs as 218 iconic American brands collapse Watch

Image of Over 200 American brands are closing stores to keep their heads above water.

An iconic American brand with a century-long history is shutting down hundreds of stores in the face of bankruptcy. LOS ANGELES, CA ... continue reading


Yes, Millennials are lazy, but it's not their fault says one high-profile consultant Watch

Image of Simon Sinek says millennials are lazy, but it isn't their fault.

Yes, Millennials, you have a problem, but it's not your fault. This is the conclusion of Simon Sinek, the famous leadership consultant who ... continue reading


Never Miss any Updates!

Stay up to date with the latest news, information, and special offers.

Catholic Online Logo

Copyright 2017 Catholic Online. All materials contained on this site, whether written, audible or visual are the exclusive property of Catholic Online and are protected under U.S. and International copyright laws, © Copyright 2017 Catholic Online. Any unauthorized use, without prior written consent of Catholic Online is strictly forbidden and prohibited.